NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-069-2000-2-CA-03 PREPARATION AND USE OF ANDROGENIC COMPOUNDS CA National Stage 2402524 Abandoned
NICHD E-069-2000-2-GB-11 Methods Of Making And Using 7a, 11B-Dimethyl-17B-Hydroxy-4-Estren-3- One 17B-Trans-4-n-Butylcyclohexane Corboxylate And 7a 11B-Dimethyl... GB EP 01922911.1 Abandoned
NICHD E-069-2000-2-DE-09 Methods Of Making And Using 7a, 11B-Dimethyl-17B-Hydroxy-4-Estren-3- One 17B-Trans-4-n-Butylcyclohexane Corboxylate And 7a 11B-Dimethyl... DE EP 01922911.1 Abandoned
NICHD E-069-2000-2-FR-10 Methods Of Making And Using 7a, 11B-Dimethyl-17B-Hydroxy-4-Estren-3- One 17B-Trans-4-n-Butylcyclohexane Corboxylate And 7a 11B-Dimethyl... FR EP 01922911.1 Abandoned
NICHD E-069-2000-2-EP-05 Methods Of Making And Using 7a, 11B-Dimethyl-17B-Hydroxy-4-Estren-3- One 17B-Trans-4-n-Butylcyclohexane Corboxylate And 7a 11B-Dimethyl... EP National Stage 01922911.1 Abandoned
NICHD E-069-2000-2-AU-04 PREPARATION AND USE OF ANDROGENIC COMPOUNDS AU National Stage 2001249661 Abandoned
NIA E-134-2001-0-US-01 Lever-Coil Sensor For Respiratory And Cardiac Motion US ORD 09/822,881 6535754 Abandoned PDF
NIAID E-189-1998-0-US-03 Inhibitors of Formation of Protease Resistant Prion Protein US DIV 09/823,494 6355610 Abandoned PDF
CC E-046-2000-0-PCT-02 Magnetic-Responsive Dendrimer Composition And Its Use In Magnetic Resonance Analysis PCT PCT PCT/US01/10387 Expired
NICHD E-069-2000-2-PCT-01 Methods Of Making And Using 7a, 11B-Dimethyl-17B-Hydroxy-4-Estren-3- One 17B-Trans-4-n-Butylcyclohexane Corboxylate And 7a 11B-Dimethyl... PCT PCT COMB PCT/US2001/010293 Expired
NICHD E-069-2000-2-EP-08 PREPARATION AND USE OF ANDROGENIC COMPOUNDS EP DIV 01922911.1 Abandoned
NCI E-004-2001-1-US-01 Geldanamycin Derivative Having Selective Affinity For HSP90 Over GRP94 And Method Of Using Same US 60/280,016 Abandoned
NCI E-050-2000-0-US-01 Geldanamycin Derivative And Method of Treating Cancer Using Same US 60/280,078 Abandoned
NCI E-056-2000-0-PCT-02 T-CELL EPITOPE OF MAGE-12 AND RELATED NUCLEIC ACIDS, VECTORS, CELLS, COMPOSITIONS AND METHODS OF INDUCING AN IMMUNE RESPONSE TO CANCER PCT PCT PCT/US01/10312 Abandoned
CC E-086-2000-0-PCT-02 Gene Profiling Arrays PCT PCT PCT/US2001/009993 Expired
NIDCR E-131-2001-0-US-01 Interactions of AAV4 With Sialic Acid US 60/279,392 Abandoned
NIDCR E-145-2001-0-US-01 Interactions of AAV5 with Sialic Acid (as filed) US 60/279,283 Abandoned
NICHD E-089-2001-0-US-01 Suppression of CCR5- BUT Not CXCR4-Tropic HIV-1 Replication in Lymphoid Tissue By Human Herpes Virus 6 US 60/279,568 Abandoned
NIAID E-275-2000-2-US-01 Modifications of HIV Env, Gag, And Pol Enhance Immunogenicity For Genetic Immunization US 60/279,257 Abandoned
NCI E-004-2001-0-US-01 Geldanamycin Derivative Having Selective Affinity For HSP90 Over GRP94 And Method Of Using Same US 60/279,020 Abandoned
NCI E-257-2008-0-US-09 Melanoma Associated Peptide Analogues And Vaccines Against Melanoma US CON 10/808,681 Abandoned
NIDDK E-015-2000-0-AU-04 ANTIPROGESTINS WITH PARTIAL AGONIST ACTIVITY AU National Stage 2001249408 Abandoned
NCI E-221-1989-0-JP-17 DNA SEGMENT ENCODING A GENE FOR A RECEPTOR RELATED TO THE EPIDERMAL GROWTH FACTOR RECEPTOR (erbB-3) JP DIV 2001-085000 Expired
NIEHS E-067-2000-0-US-02 FLUORESCENT MAGNESIUM INDICATORS US ORD 09/816,638 6706528 Abandoned PDF
NEI E-220-2001-0-US-01 Nutritional Supplement to Treat Macular Degeneration US ORD 09/816,284 6660297 Expired PDF
NIDDK E-015-2000-0-PCT-02 ANTIPROGESTINS WITH PARTIAL AGONIST ACTIVITY PCT PCT PCT/US01/09395 Expired
NIMH E-171-2001-0-US-01 METHODS FOR TREATING NEURODEGENERATIVE DISEASES INCLUDING ALZHEIMER'S US ORD 09/816,289 Abandoned
NIDDK E-015-2000-0-JP-06 ANTIPROGESTINS WITH PARTIAL AGONIST ACTIVITY JP National Stage 2001-570254 Abandoned
NIDDK E-015-2000-0-EP-03 ANTIPROGESTINS WITH PARTIAL AGONIST ACTIVITY EP National Stage 01922626.5 Abandoned
NCI E-126-2001-0-US-01 Human Papilloma Virus Immunogenic Peptides US 60/278,520 Abandoned
NIDDK E-015-2000-0-CA-05 ANTIPROGESTINS WITH PARTIAL AGONIST ACTIVITY CA National Stage 2404172 Abandoned
NIDCR E-109-2000-0-CA-03 SELECTIVE ABLATION OF PAIN-SENSING NEURONS BY ADMINISTRATION OF A VANILLOID RECEPTOR AGONIST CA National Stage 2442049 Expired
NCI E-074-1999-3-US-01 Glycosylation-Resistant Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using Nonglycosylated Cyanovirins US CIP 09/815,079 6780847 Abandoned PDF
NIEHS E-103-2000-0-US-02 DMT-TIC DI-AND TRI-Peptide derivatives and related Compositions and Methods of Use US ORD 09/814,558 6753317 Abandoned PDF
NCI E-117-1995-0-US-05 Conjugates of Antiviral Proteins or Peptides And Virus or Viral Envelope Glycoproteins US DIV 09/814,884 6586392 Expired PDF
NIA E-087-2000-0-PCT-02 ESTABLISHMENT OF CELLULAR MANIPULATIONS WHICH ENCHANCE OLIGO MEDIATED GENE TARGETING. PCT PCT PCT/US2001/009218 Expired
NHLBI E-072-2000-0-PCT-02 AAV5 Vector For Transducing Brain Cells and Lung Cells PCT PCT PCT/US2001/009123 Abandoned
NCI E-008-1998-0-US-04 B2 Microglobulin Fusion Proteins and High Affinity Variants US ORD 09/719,243 6682741 Abandoned PDF
NIAID E-200-1997-0-US-03 Methods of Treating Colitis Using Stat-4 Anti-Sense Oligonucleotides US CON 09/812,028 6479465 Abandoned PDF
NCI E-033-2001-0-US-01 Novel TRP2 Isoform Containing HLA-A2 Restricted Cytotoxic T Lymphocyte Epitopes US 60/277,108 Abandoned
NINDS E-105-1993-1-US-18 USE OF NEURO-DERIVED FETAL CELL LINES FOR TRANSPLANTATION THERAPY US CON 09/270,756 Abandoned
NICHD E-155-1999-0-EP-28 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents EP DIV 10010646.7 Abandoned
NICHD E-155-1999-0-NL-41 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents NL EP 10010646.7 Abandoned
NICHD E-155-1999-0-BE-34 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents BE EP 10010646.7 Abandoned
NICHD E-155-1999-0-AT-33 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents AT EP 10010646.7 Abandoned
NICHD E-155-1999-0-FR-38 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents FR EP 10010646.7 Abandoned
NICHD E-155-1999-0-DE-36 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents DE EP 10010646.7 Abandoned
NICHD E-155-1999-0-SE-42 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents SE EP 10010646.7 Abandoned
NICHD E-155-1999-0-CH-35 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents CH EP 10010646.7 Abandoned
NICHD E-155-1999-0-GB-39 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents GB EP 10010646.7 Abandoned